Market News / Story
Quince Therapeutics appoints Brigette Roberts as CEO; John Militello named CFO
·
Quince Therapeutics appointed Brigette Roberts as Chief Executive Officer and John Militello as Chief Financial Officer, effective October 8, 2026, following Dirk Thye's resignation as CEO and Brendan Hannah's resignation as COO. IndividualBrigette Roberts, M.D.John Militello, CPAKeith Fandrick, Ph.D.Dirk Thye, M.D.Brendan HannahCatherine M. Bonuccelli, M.D.Leone PattersonJames ValentineDrayton WiseRoleChief Executive Officer; directorChief Financial OfficerChief…